KR20020031338A - 모르핀술페이트 마이크로그래뉼, 이의 제조방법 및 이를함유하는 조성물 - Google Patents
모르핀술페이트 마이크로그래뉼, 이의 제조방법 및 이를함유하는 조성물 Download PDFInfo
- Publication number
- KR20020031338A KR20020031338A KR1020017015784A KR20017015784A KR20020031338A KR 20020031338 A KR20020031338 A KR 20020031338A KR 1020017015784 A KR1020017015784 A KR 1020017015784A KR 20017015784 A KR20017015784 A KR 20017015784A KR 20020031338 A KR20020031338 A KR 20020031338A
- Authority
- KR
- South Korea
- Prior art keywords
- morphine sulfate
- sustained release
- micro granules
- granules
- micro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
- 각각 활성층 및 지속방출층으로 코팅된 중성 지지 입자체를 포함하는 지속방출형 모르핀술페이트 마이크로그래뉼에 있어서, 지속방출층은 유리 카복시기 및 에스테르기의 상대비율이 약 0.5인 메타크릴산과 메틸메타크릴레이트에스테르의 공중합체 및 소수성을 나타내는 실리카를 함유하는 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 1 항에 있어서, 소수성 실리카는 마이크로그래뉼 중량에 대하여 0.2∼1%를 나타내는 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 1 항 또는 제 2 항에 있어서, 아크릴산 공중합체는 마이크로그래그뉼 중량에 대하여 5∼15%를 나타내는 것이 유리한 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 활성층으로 코팅된 중성 지지 입자체는 모르핀술페이트 40∼50% 및 약제학적으로 허용가능한 바인더 10∼20%를 함유하는 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 1 항 내지 제 4 항 중 어느 한 항에 있어서, 지속방출층은 트리에틸시트레이트와 같은 가소제 및 윤활제를 함유하는 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 4 항 또는 제 5 항에 있어서, 마이크로그래뉼의 조성은 하기와 같은 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.모르핀술페이트 30∼40%중성 지지 입자체 30∼40%바인더 10∼20%메타크릴산 공중합체 5∼15%가소제 1∼2.5%윤활제 2∼4%소수성 실리카 0.2∼1%
- 제 1 항 내지 제 6 항 중 어느 한 항에 있어서, 모르핀술페이트 및 중성 지지 입자체의 상대질량비율은 40/60 내지 60/40인 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 제 1 항 내지 제 7 항 중 어느 한 항에 있어서, 모르핀술페이트는 마이크로그래뉼 질량에 대하여 30∼40%를 나타내는 것을 특징으로 하는 지속방출형 모르핀술페이트 마이크로그래뉼.
- 활성층 및 지속방출층을 수용액에 정치하여 중성 입자체에 도포하는 것을 특징으로 하는 제 1 항 내지 제 8 항 중 어느 한 항의 마이크로그래뉼의 제조방법.
- 제 9 항의 방법에 따라 임의로 얻어진 제 1 항 내지 제 8 항 중 어느 한 항의 마이크로그래뉼을 함유하는 약제학적 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9907259A FR2794646B1 (fr) | 1999-06-09 | 1999-06-09 | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
FR99/07259 | 1999-06-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020031338A true KR20020031338A (ko) | 2002-05-01 |
KR100676123B1 KR100676123B1 (ko) | 2007-01-31 |
Family
ID=9546553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017015784A KR100676123B1 (ko) | 1999-06-09 | 2000-06-08 | 모르핀술페이트 마이크로그래뉼, 이의 제조방법 및 이를함유하는 조성물 |
Country Status (24)
Country | Link |
---|---|
US (2) | US7063864B1 (ko) |
EP (3) | EP1189602B1 (ko) |
JP (1) | JP4296562B2 (ko) |
KR (1) | KR100676123B1 (ko) |
CN (1) | CN1267089C (ko) |
AR (2) | AR024313A1 (ko) |
AT (2) | ATE354356T1 (ko) |
AU (1) | AU769160C (ko) |
BR (1) | BRPI0011404B8 (ko) |
CA (1) | CA2376339C (ko) |
CO (1) | CO5160317A1 (ko) |
CY (1) | CY1107612T1 (ko) |
DE (1) | DE60033519T2 (ko) |
DK (2) | DK1189602T3 (ko) |
ES (2) | ES2280226T3 (ko) |
FR (1) | FR2794646B1 (ko) |
HK (1) | HK1045107B (ko) |
MX (1) | MXPA01012751A (ko) |
NZ (1) | NZ516077A (ko) |
PT (2) | PT1189602E (ko) |
SI (1) | SI1189602T1 (ko) |
TW (1) | TWI224510B (ko) |
WO (1) | WO2000074659A1 (ko) |
ZA (1) | ZA200110087B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2794646B1 (fr) * | 1999-06-09 | 2001-09-21 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
JP4848101B2 (ja) * | 2001-08-17 | 2011-12-28 | 株式会社フジモト・コーポレーション | 徐放性マイクロペレット |
EP1429739A1 (en) | 2001-09-21 | 2004-06-23 | Egalet A/S | Polymer release system |
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
ATE495732T1 (de) | 2003-03-26 | 2011-02-15 | Egalet As | Morphin-system mit kontrollierter freisetzung |
FR2883179B1 (fr) * | 2005-03-18 | 2009-04-17 | Ethypharm Sa | Comprime enrobe |
US20070286900A1 (en) * | 2006-06-09 | 2007-12-13 | Catherine Herry | Low dose tablets of opioid analgesics and preparation process |
US20100233257A1 (en) * | 2006-06-09 | 2010-09-16 | Ethypharm | Low dose sublingual tablets of opioid analgesics and preparation process |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
NZ603579A (en) | 2009-06-24 | 2014-02-28 | Egalet Ltd | Controlled release formulations |
US20190038769A1 (en) * | 2010-12-01 | 2019-02-07 | Gowey Research Group, Pllc | Micro-rna profiling, compositions, and methods of treating diseases |
JP2012250926A (ja) * | 2011-06-01 | 2012-12-20 | Nitto Denko Corp | 粒子製剤 |
KR20150059167A (ko) | 2012-07-06 | 2015-05-29 | 에갈렛 리미티드 | 제어된 방출을 위한 남용 제지 약학적 조성물 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8514665D0 (en) | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
GB9117361D0 (en) * | 1991-08-12 | 1991-09-25 | Euro Celtique Sa | Oral dosage form |
GB9119958D0 (en) | 1991-09-18 | 1991-10-30 | Unilever Plc | Detergent compositions |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
SE9301057L (sv) | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Beredning med kontrollerad frisättning |
EP1442745A1 (en) * | 1993-10-07 | 2004-08-04 | Euro-Celtique | Orally administrable opioid formulations having extended duration of effect |
US5411745A (en) | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
US5460826A (en) | 1994-06-27 | 1995-10-24 | Alza Corporation | Morphine therapy |
GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
FR2794646B1 (fr) * | 1999-06-09 | 2001-09-21 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
-
1999
- 1999-06-09 FR FR9907259A patent/FR2794646B1/fr not_active Expired - Lifetime
-
2000
- 2000-06-06 CO CO00041883A patent/CO5160317A1/es unknown
- 2000-06-07 AR ARP000102831A patent/AR024313A1/es not_active Application Discontinuation
- 2000-06-08 BR BRPI0011404A patent/BRPI0011404B8/pt not_active IP Right Cessation
- 2000-06-08 JP JP2001501196A patent/JP4296562B2/ja not_active Expired - Lifetime
- 2000-06-08 ES ES00940460T patent/ES2280226T3/es not_active Expired - Lifetime
- 2000-06-08 ES ES05111290T patent/ES2379688T3/es not_active Expired - Lifetime
- 2000-06-08 EP EP00940460A patent/EP1189602B1/fr not_active Expired - Lifetime
- 2000-06-08 AT AT00940460T patent/ATE354356T1/de active
- 2000-06-08 CA CA2376339A patent/CA2376339C/fr not_active Expired - Lifetime
- 2000-06-08 CN CNB008086052A patent/CN1267089C/zh not_active Expired - Lifetime
- 2000-06-08 AT AT05111290T patent/ATE544448T1/de active
- 2000-06-08 NZ NZ516077A patent/NZ516077A/en not_active IP Right Cessation
- 2000-06-08 PT PT00940460T patent/PT1189602E/pt unknown
- 2000-06-08 DK DK00940460T patent/DK1189602T3/da active
- 2000-06-08 KR KR1020017015784A patent/KR100676123B1/ko active IP Right Grant
- 2000-06-08 DE DE60033519T patent/DE60033519T2/de not_active Expired - Lifetime
- 2000-06-08 EP EP07102671A patent/EP1818051A1/fr not_active Withdrawn
- 2000-06-08 PT PT05111290T patent/PT1627631E/pt unknown
- 2000-06-08 DK DK05111290.2T patent/DK1627631T3/da active
- 2000-06-08 SI SI200030946T patent/SI1189602T1/sl unknown
- 2000-06-08 AU AU55394/00A patent/AU769160C/en not_active Expired
- 2000-06-08 US US10/009,341 patent/US7063864B1/en not_active Expired - Lifetime
- 2000-06-08 MX MXPA01012751A patent/MXPA01012751A/es active IP Right Grant
- 2000-06-08 EP EP05111290A patent/EP1627631B1/fr not_active Expired - Lifetime
- 2000-06-08 WO PCT/FR2000/001573 patent/WO2000074659A1/fr active IP Right Grant
- 2000-06-27 TW TW089111207A patent/TWI224510B/zh not_active IP Right Cessation
-
2001
- 2001-12-07 ZA ZA200110087A patent/ZA200110087B/xx unknown
-
2002
- 2002-08-13 HK HK02105909.7A patent/HK1045107B/zh unknown
-
2006
- 2006-05-26 US US11/441,349 patent/US20070003620A1/en not_active Abandoned
-
2007
- 2007-04-05 CY CY20071100489T patent/CY1107612T1/el unknown
-
2008
- 2008-08-22 AR ARP080103672A patent/AR068015A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950005864B1 (ko) | 서방성 제제 및 그의 제조방법 | |
JP3009467B2 (ja) | 放出持続性ジルチアゼム製剤 | |
KR100316206B1 (ko) | 모르핀의염을함유하는방출조절식제제 | |
KR940000100B1 (ko) | 메토프롤롤염을 함유하는 서방형 제제의 제조방법 | |
US6066339A (en) | Oral morphine multiparticulate formulation | |
US5674533A (en) | Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension | |
EP0640337B1 (en) | Controlled release-initiation and controlled release-rate pharmaceutical composition | |
JP3157182B2 (ja) | 一日一回投与のための吸収の制御されたナプロキセン配合物 | |
JP2560019B2 (ja) | 活性化合物の放出を制御する新規な製剤およびその製造法 | |
KR101632368B1 (ko) | 미소 과립을 함유하는 알코올 저항성 서방형 경구 의약 제형 | |
US20070003620A1 (en) | Morphine sulfate microgranules, method for preparing same and compositions containing same | |
DE4200821A1 (de) | Geschmacksmaskierte pharmazeutische mittel | |
US20110189269A1 (en) | Extended release composition containing tramadol | |
US4826688A (en) | Controlled absorption pharmaceutical formulation | |
IE58401B1 (en) | Controlled absorption pharmaceutical composition | |
JP2002529401A (ja) | 水溶性薬物の放出制御製剤 | |
AU1170499A (en) | Spheroids, preparation method and pharmaceutical compositions | |
KR970001656B1 (ko) | 조절흡수 딜티아젬 제제 | |
EP0378137A2 (de) | Neue Arzneiform | |
KR100354054B1 (ko) | 유효성분으로서딜티아젬을함유하는지속방출형마이크로그래뉼 | |
CA2541578C (en) | Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these | |
GB2098867A (en) | Sustained release pharmaceutical composition | |
CA2647765A1 (en) | Coated formulations | |
AU732210B2 (en) | Colonic delivery of weak acid drugs | |
KR20010006647A (ko) | 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130121 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140102 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150123 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160104 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180110 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190102 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 14 |